Tyler J. Zemla, MS

Principal Biostatistician
Alliance Statistics and Data Management Center, United States

Presentation(s):

• 45: Postoperative Complications Following Neoadjuvant Therapy and Surgery in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501)

  Thursday, March 21, 2024
  2:32pm – 2:42pm ET